Greater China
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works -
Deal comes as lenders remain cautious about risks in the real estate industry
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works
-
The two firms are testing investor appetite for their listings
-
The developer is looking to extend the maturity of its dollar bond by two years
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works
-
Chinese cancer immunotherapy drug producer parks over half of the deal with cornerstone investors
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works
-
Immediate funding needs are driving companies to the debt market despite weak conditions
-
This round-up focuses on protests in major Chinese cities and fresh impetus for the property sector
-
In this table, GlobalCapital Asia offers a glimpse of the bond deals that are in the works
-
Gaush Meditech is seeking about $80m, and Weilong Global roughly $200m
